drugset / Trial / NCT03765957

Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells

NCT03765957

Phase 0 Unknown 12 enrolled Central South University
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the effect and safety of treatment of psoriasis by human umbilical cord-derived mesenchymal stem cel

Timeline

Start
2019-02-20
Primary completion
2020-07-31
Completion
2021-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject mesenchymal stem cells Cell therapy 1.5e+06 cells/kg Intravenous
Subject mesenchymal stem cells Cell therapy 2e+06 cells/kg Intravenous
Subject mesenchymal stem cells Cell therapy 2.5e+06 cells/kg Intravenous
Subject mesenchymal stem cells Cell therapy 3e+06 cells/kg Intravenous

Indications